About: Cholecalciferol

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cholecalciferol Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/drugbank/Drug, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	http://linked.opendata.cz/ontology/drugbank/Drug
http://linked.open...gbank/description	Derivative of 7-dehydroxycholesterol formed by ultraviolet rays breaking of the C9-C10 bond. It differs from ergocalciferol in having a single bond between C22 and C23 and lacking a methyl group at C24. [PubChem] (en)
http://linked.open...generalReferences	# Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004 Nov;89(11):5387-91. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/15531486 (en)
http://linked.open...gy/drugbank/group	approved (en) nutraceutical (en)
http://linked.open...drugbank/halfLife	Several weeks (en)
http://linked.open...ugbank/indication	For the treatment of vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis. (en)
sameAs	Cholecalciferol Cholecalciferol
Title	Cholecalciferol (en)
adms:identifier	http://linked.opendata.cz/resource/drugbank/drug/DB00169/identifier/chebi/28940 http://linked.opendata.cz/resource/drugbank/drug/DB00169/identifier/drugbank/DB00169 http://linked.opendata.cz/resource/drugbank/drug/DB00169/identifier/kegg-compound/C05443 http://linked.opendata.cz/resource/drugbank/drug/DB00169/identifier/kegg-drug/D00188 http://linked.opendata.cz/resource/drugbank/drug/DB00169/identifier/pharmgkb/PA164748138 http://linked.opendata.cz/resource/drugbank/drug/DB00169/identifier/wikipedia/Cholecalciferol
http://linked.open...mechanismOfAction	The first step involved in the activation of vitamin D3 is a 25-hydroxylation which is catalysed by the 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyses the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains. The vitamin D receptor forms a complex with another intracellular receptor, the retinoid-X receptor, and that heterodimer is what binds to DNA. In most cases studied, the effect is to activate transcription, but situations are also known in which vitamin D suppresses transcription. Calcitriol increases the serum calcium concentrations by: increasing GI absorption of phosphorus and calcium, increasing osteoclastic resorption, and increasing distal renal tubular reabsorption of calcium. Calcitriol appears to promote intestinal absorption of calcium through binding to the vitamin D receptor in the mucosal cytoplasm of the intestine. Subsequently, calcium is absorbed through formation of a calcium-binding protein. (en)
http://linked.open...drugbank/packager	Chain Drug CVS Pharmacy Freeda Vitamins Major Pharmaceuticals Mason Distributors Medisca Inc. MSD Frosst Iberica SA Nycomed Inc. Palmetto Pharmaceuticals Inc. Breckenridge Pharmaceuticals Lundbeck Inc.
http://linked.open.../drugbank/synonym	Colecalciferol (en) Cholecalciferol (en) Oleovitamin D3 (en) (+)-vitamin D3 (en) CC (en) Vitamin D3 (en) calciol (en) Activated 7-dehydrocholesterol (en) (1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol (en) delta-D (en) (3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol (en) (5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol (en)
http://linked.open...drugbank/toxicity	Hypercalcemia - Early symptoms of hypercalcemia, include nausea and vomiting, weakness, headache, somnolence, dry mouth, constipation, metallic taste, muscle pain and bone pain. Late symptoms and signs of hypercalcemia, include polyuria, polydipsia, anorexia, weight loss, nocturia, conjunctivitis, pancreatitis, photophobia, rhinorrhea, pruritis, hyperthermia, decreased libido, elevated BUN, albuminuria, hypercholesterolemia, elevated ALT (SGPT) and AST (SGOT), ectopic calcification, nephrocalcinosis, hypertension and cardiac arrhythmias. (en)
http://linked.open.../drug/hasAHFSCode	http://linked.opendata.cz/resource/AHFS/88-16-00
http://linked.open.../drugbank/mixture	Spectrum Spectrum Forte Spectrum Gold Watkin's Super Multi Watkins J.R.
http://linked.open...nk/proteinBinding	50% to 80% (en)
http://linked.open...ynthesisReference	Jean Jolly, Primo Rizzi, Jean Taillardat, "1.alpha.,25.alpha.-Dihydroxy-cholecalciferol and methods for the production thereof." U.S. Patent US4435325, issued May, 1977. (en)
http://linked.open...y/mesh/hasConcept	http://linked.opendata.cz/resource/mesh/concept/M0004229
foaf:page	http://www.drugs.com/mtm/cholecalciferol.html http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0265.shtml
http://linked.open...ugbank/IUPAC-Name	http://linked.opendata.cz/resource/drugbank/property/271B5033-363D-11E5-9242-09173F13E4C5
http://linked.open...gy/drugbank/InChI	http://linked.opendata.cz/resource/drugbank/property/271B5039-363D-11E5-9242-09173F13E4C5
http://linked.open...Molecular-Formula	http://linked.opendata.cz/resource/drugbank/property/271B5038-363D-11E5-9242-09173F13E4C5
http://linked.open.../Molecular-Weight	http://linked.opendata.cz/resource/drugbank/property/271B5035-363D-11E5-9242-09173F13E4C5
http://linked.open...noisotopic-Weight	http://linked.opendata.cz/resource/drugbank/property/271B5036-363D-11E5-9242-09173F13E4C5
http://linked.open...y/drugbank/SMILES	http://linked.opendata.cz/resource/drugbank/property/271B5037-363D-11E5-9242-09173F13E4C5
http://linked.open.../Water-Solubility	http://linked.opendata.cz/resource/drugbank/property/271B5031-363D-11E5-9242-09173F13E4C5 http://linked.opendata.cz/resource/drugbank/property/271B5049-363D-11E5-9242-09173F13E4C5
http://linked.open...ogy/drugbank/logP	http://linked.opendata.cz/resource/drugbank/property/271B502F-363D-11E5-9242-09173F13E4C5 http://linked.opendata.cz/resource/drugbank/property/271B5032-363D-11E5-9242-09173F13E4C5 http://linked.opendata.cz/resource/drugbank/property/271B504B-363D-11E5-9242-09173F13E4C5
http://linked.open...ogy/drugbank/logS	http://linked.opendata.cz/resource/drugbank/property/271B5030-363D-11E5-9242-09173F13E4C5
http://linked.open...l/drug/hasATCCode	Colecalciferol
http://linked.open...nd-Acceptor-Count	http://linked.opendata.cz/resource/drugbank/property/271B503F-363D-11E5-9242-09173F13E4C5
http://linked.open...-Bond-Donor-Count	http://linked.opendata.cz/resource/drugbank/property/271B5040-363D-11E5-9242-09173F13E4C5
http://linked.open...drugbank/InChIKey	http://linked.opendata.cz/resource/drugbank/property/271B503A-363D-11E5-9242-09173F13E4C5
http://linked.open...urface-Area--PSA-	http://linked.opendata.cz/resource/drugbank/property/271B503B-363D-11E5-9242-09173F13E4C5
http://linked.open...nk/Polarizability	http://linked.opendata.cz/resource/drugbank/property/271B503D-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Refractivity	http://linked.opendata.cz/resource/drugbank/property/271B503C-363D-11E5-9242-09173F13E4C5
http://linked.open...atable-Bond-Count	http://linked.opendata.cz/resource/drugbank/property/271B503E-363D-11E5-9242-09173F13E4C5
http://linked.open...ugbank/absorption	Readily absorbed (en)
http://linked.open.../affectedOrganism	Humans and other mammals (en)
http://linked.open...casRegistryNumber	67-97-0 (en)
http://linked.open...drugbank/category	(en)
http://linked.open...gbank/containedIn	Cholecalciferol crystals Nitroglycerin CR 2.5 mg capsule Nitro-bid 2% ointment Nitroglycerin 9 mg capsule sa Medrol (Pak) 21 4 mg tablet Disp Pack CVS Pharmacy vitamin d 1000 unit tablet Delta d3 400 unit tablet Minitran 0.2 0.2 mg/hr Patch Nitro-Dur 0.4 0.4 mg/hr Patch Nitro-Dur 0.6 0.6 mg/hr Patch Solu-Medrol Act-O-Vial 1 g/vial
http://linked.open...k/Bioavailability	http://linked.opendata.cz/resource/drugbank/property/271B5045-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Ghose-Filter	http://linked.opendata.cz/resource/drugbank/property/271B5047-363D-11E5-9242-09173F13E4C5
http://linked.open...nk/MDDR-Like-Rule	http://linked.opendata.cz/resource/drugbank/property/271B5048-363D-11E5-9242-09173F13E4C5
http://linked.open...ank/Melting-Point	http://linked.opendata.cz/resource/drugbank/property/271B504A-363D-11E5-9242-09173F13E4C5
http://linked.open...k/Number-of-Rings	http://linked.opendata.cz/resource/drugbank/property/271B5044-363D-11E5-9242-09173F13E4C5
http://linked.open...siological-Charge	http://linked.opendata.cz/resource/drugbank/property/271B5043-363D-11E5-9242-09173F13E4C5
http://linked.open...bank/Rule-of-Five	http://linked.opendata.cz/resource/drugbank/property/271B5046-363D-11E5-9242-09173F13E4C5
http://linked.open...tional-IUPAC-Name	http://linked.opendata.cz/resource/drugbank/property/271B5034-363D-11E5-9242-09173F13E4C5
http://linked.open...strongest-acidic-	http://linked.opendata.cz/resource/drugbank/property/271B5041-363D-11E5-9242-09173F13E4C5
http://linked.open...-strongest-basic-	http://linked.opendata.cz/resource/drugbank/property/271B5042-363D-11E5-9242-09173F13E4C5

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 121 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software